Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Prescription Labeling topic
No spam. Unsubscribe anytime.
Assembly approves bill allowing practice name on mifepristone, misoprostol labels at prescriber’s request
Summary
The Assembly passed a measure enabling prescribers to request that prescription labels for mifepristone and misoprostol display a health‑care practice name rather than an individual clinician’s name; supporters cite provider safety, opponents raised transparency and cross‑state legal concerns.
The Assembly on Wednesday approved bill 2145a (rules report 61), which allows a prescriber or dispensing practitioner to request that the prescription label for mifepristone and misoprostol display the name of a health‑care practice rather than the individual prescriber’s name.
Sponsor Assemblymember Jessica Reyes said the change responds to safety concerns for clinicians, saying the bill "would allow the prescription labels for mifepristone and misoprostol to include the name of a health care practice instead of the name of the prescribing or dispensing practitioner at their request." She said practitioners had raised fear of targeting or reprisals.
Questioners on the floor probed practical consequences. Assemblymember Durso asked how patients or pharmacies would contact a prescriber in an adverse event; Reyes said the prescription itself still contains the prescriber’s information, and that practices can be contacted to identify the clinician and pull records. Other members—including Pierisolo and Giglio—expressed concerns about placing New Yorkers who obtain medication for use outside the state in legal or medical jeopardy and about whether the change could be used to circumvent laws in other states.
Several lawmakers described the measure as a narrow, targeted change; proponents noted the bill applies only to the two named drugs. Medical and provider organizations were cited on the floor in support; a practicing clinician member described how electronic prescribing systems already carry a practice field that can be used in labels.
Opponents warned the bill could reduce transparency for patients, complicate malpractice or safety investigations and raise legal questions for prescriptions filled across state lines. The Assembly approved the measure by a recorded vote of Ayes 98, Nos 43.
The bill’s floor discussion made clear the prescription (the legal document) continues to contain the prescriber’s identifying information and license data; the change affects information printed on the pharmacy label attached to dispensed medication.
